Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Japan Issues Draft Guidance On Microdosing

This article was originally published in PharmAsia News

Executive Summary

Japan's Ministry of Health, Labor and Welfare has issued a draft guidance on microdosing in an effort to encourage companies to make quicker development decisions related to early stage compounds. The draft guidance defines a microdose as a single dose of less than 1/100th of a dose of a test substance calculated to yield a pharmacologic effect, with a maximum dose of no more than100µgs. Microdosing has been implemented in both the U.S. and European Union; the draft guidance is the first such measure in Japan. The draft guidance is expected to be implemented in Japan as early as March; MHLW is accepting comments on the document until Feb. 8. (Click here for more.

Latest Headlines
See All
UsernamePublicRestriction

Register

SC066795

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel